chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Cough, chills, nausea, muscle aches, feels absolutely terrible, feels like flu.
72 hours of 101 degree fever; intense chills and muscle ache; overall "fluishness";  fatigue for a few days thereafter.  30 days after 1st injection and one day before the 2nd shot: generalized upper torso rash, may or may not be related .  Still present 4 days after 2nd shot.
HPV Vax given 7-5-17, felt "off" the next day. The following day had diarrhea, nausea. 4 days after admin still felt "off" "blah" and had headache. Talked w/Mom on 5th day. Seen by provider on day 6 post vax for headache, abdominal pain.
1:20PM SYNCOPAL EPISODE. PT PLACED ON FLOOR AND FEET ELEVATED. PT BECAME RESPONSIVE, PALE, DIAPHORETIC. SAT PT UP AND HE BECAME WOOZY. MOVED TO COT.  1:28PM A/O, PINK, W/D, RESP REG WITH EASE. NO PAIN, NO SOB. 1:40PM "FEELS BETTER NOW'. WIFE TO DRIVE PT HOME. NO ACUTE DISTRESS. 4-2-21 9AM PT STATES HE 'FEELS GREAT NOW'.
Dizzy on morning of 9th day upon waking. Lasted about an hour. Stayed in bed until it passed. I have never ever experienced dizziness.
A rash surrounding the injection site appeared at 2 days after the vaccination, resolved after approximately 24-48 hours with self treatment, and then it appeared again 8 days later after initial vaccination, lasting again at least 48 hours with continuing self treatment. The  rash was approximately 1 inch diameter around injection site with itching, redness, and swelling . It was self treated with Hydrocortisone topical cream.
LIGHT SORENESS ON ARM; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 16-MAR-2021 at around 11:00 AM for prophylactic vaccination. The batch number was not reported. We are unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 16-MAR-2021, the subject experienced light soreness on arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of light soreness on arm was not reported. This report was non-serious.
Fever, chills, muscle cramps, fatigue; lasted until ~ 12:30 pm. that day.
Information has been received from a 69 year old female with no pertinent medical history and no known drug allergies, who on 29-NOV-2007 was vaccinated with ZOSTAVAX (Oka/Merck). Concomitant therapy included vitamins (unspecified), flaxseed oil, ESTROVEN (NEW FORMULA). A day after getting the vaccine, (30-NOV-2007) the patient reported that she felt "a little bit itchy" at the injection site. It was indicated that there were no blisters, "just a little red". The patient reported that her physician recommended that she wash the area with hydrogen peroxide. There were no laboratory or diagnostic studies performed. On an unspecified date, the patient recovered. A product quality complaint was not requested. Additional information has been requested. Follow-up information from the patient indicated she requested to have ZOSTAVAX (Oka/Merck).
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021 at 1:45 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021 at 1:51 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant products were not provided.  Age of patient was reported as 61.42 for dose administered on 02-Mar-2021 and 61.50 for dose administered on 30-Mar-2021.  For Batch number 014M20A On 02-Mar-2021, Excursion time were at 09 AM was 27, at 10PM, temp was 29, at 11 AM, temp was 32, at 12PM, temp was 33, at 02PM, temp was 35, at 03 PM, temp was 36, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 24-Feb-2021, vial was moved to clinic on o2-Mar-2021. 16 vial was moved to clinic. Vaccine BUD date was 26-Mar-2021. For Batch 019B21A On 30-Mar-2021, Excursion time were 9 AM, temp was 33 ,  total doses given for the day was 173, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 30-Mar-2021. 3 vial was moved to clinic. Vaccine BUD date was 22-Apr-2021  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34- or 35-degree F.   The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken by using a brand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided
After receiving the shot, I was directed to the 30-minute wait section because I disclosed that I am highly allergic to sulfa. About 2 minutes after sitting down, I started having difficulty breathing and became very dizzy. It was if I could literally feel the vaccine rush through my body and even down into my legs. It felt like heat in my legs. I wanted to remove my mask to try to breathe, but I knew I should not. I am a single parent and my child was at home attending remote school so I was thinking I did not want to go to the hospital. I instantly prayed and paced my breathing as I struggled and began to sweat. I began slowly moving my legs because I started thinking about the J&J blood clot issues and prayed more. The ladies monitoring the section were at the front of my section and I was in the very back, so I could not alert anyone. I struggled and prayed about 10 minutes until my breathing improved (through prayer), but I was still dizzy. I sat there over 30 minutes because I was fearful to stand. I finally got up, but was still dizzy and lethargic. I called my mother and sat in my truck in the parking lot for another 30 minutes because I was not capable of driving. For approximately one week, I had tempered breathing, was very nauseous, fatigued, and lethargic. Interesting enough, I had only minor pain in my arm.
developped a right eye bleed, 75% of my eye was covered with blood; developed a yellow cloud/ area on my right eye; This is a spontaneous report from a contactable consumer.  A 53-year-old male consumer reported that he received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number 59267-1000-1),  into the right arm on 03Mar2021 at 12:45 AM at single dose for COVID-19 immunization. The patient had known allergies to Bactrim/Sulfa. Concomitant drugs in two weeks were none. On 18Mar2021 at 06:00 AM the patient developed a yellow cloud/ area on his right eye , developped a right eye bleed on 18Mar2021 which lasted on off untill 27Mar2021. 75% of his eye was covered with blood. The blood was clearing but the cloud remained. The patient underwent eye exam and received eye drops/tears. The patient was Covid tested post vaccination with Nasal Swab and antigen with negative result.
question of sz p/1st dose of HIB/DTP/OPV & 2nd Hep B w/in 24 hrs p/vax;
Patient had soreness in the arm for 4 days, but the real complaint is vertigo attacks that began the night after the vaccination. Three 5 minute long vertigo attacks have happened to the patient: one attack the night after the vaccination, one later that next day, and one on the 3rd day after the vaccination. The patient still feels "off" and is concerned that an attack could happen again. He has never had vertigo in the past.
Patient received dose #1 of covid-19 vaccine at approximately 6:55PM. After 10-15 minutes, patient reported difficulty breathing and "sticky" feeling in throat. Patient stated she was prone to panic attacks. EMS was called for further evaluation to determine if patient wants to go to hospital for follow up.
Information has been received concerning a pt who was exposed to his vaccinated sister who had a varicella like rash. This pt had not been vaccinated with varicella vaccine. It was reported that the lesions and a fever started on 06/26/22. On 06/28/00, the pt developed a secondary transmission when he broke out with a full blown case of chickenpox. The pt's parents do not know if exposure to wild type virus occurred. The reporter indicated that a vesicular fluid specimen and a swab will be sent for analysis. The pt  sought unspecified medical attention. Follow up information from the laboratory indicated that the results of the pt's test performed on 06/30/00 were negative for varicella zoster. The pt recovered.
pt recv vax 24APR98 & same day approx 2hr post vax pt devel sweaty palms w/a T101.8 & became flushed, shaky & dizzy;
This report is regarding the Pfizer COVID-19 vaccination you received on the above date, which was lot number FD0809. The Public Health District, per guidance from the Department of Health, Centers for Disease Control (CDC), and Pfizer have determined that the dose of vaccine that you received is valid.
Covid positive 7/18/21, acute hypoxic respiratory failure, intubated 7/22/21
Received vaccine dose 2 around 11am, started with a fever, chills, headache, and body aches around 10pm. Tylenol was taken around midnight but did not break the fever or aid in body aches.  Fever, headache, and body aches continued through next day until around 11pm. Highest recorded fever was 102 about 24 hrs after vaccine (felt higher throughout the night but no access to thermometer at that time). Tylenol was taken every 6 hours, only suppressing fever and aches slightly for about 4 hours after taking it.
Information has been received from a physician via Company representative concerning a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 21-SEP-2015, the patient was vaccinated with an improperly stored dose of GARDASIL "10x1 sdv" (Lot No. K001631, exp. 24-FEB-2017) (dose and site not reported). The vaccine was in excursion with a sum of hours of 80, 1172, 336, 24, 416 and 168. The lowest recorded temperatures were of 30 and -3. The highest recorded temperatures were 59, 48, 47 and 49. The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Systemic: Rash (other than injection site), Systemic: Chills, Systemic: Generalized Body Aches , Systemic: Headache, Systemic: Other- swelling and itchiness of the eyelids, dry mouth and nose, dizziness; symptoms lasted 9 days.
Pains in upper left chest.   Pain was constant and  hurt more with each breath.   Began in the morning and lasted all day.   Pain was gone the next morning.   I did not seek medical care.
Headache, treated with acetaminophen, lasted 24 hours Body ache and chills, lasted 36 hours, went away naturally
Sudden red rash appearing few hours post shots, very thick rash covering face, chest, arms, back upper torso, Fever 97.4 ax, Alert and oriented, Cheerful and eating candy, Going to PMD @ 1 pm.
Muscle spasm; Shaking; This spontaneous case was reported by a patient and describes the occurrence of MUSCLE SPASMS (Muscle spasm) and TREMOR (Shaking) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033K21-2A, 012F21A, 039A21A and 002A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Date of positive COVID-19 test: 20/21Nov2020) on 20-Nov-2020.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2022, the patient experienced MUSCLE SPASMS (Muscle spasm) and TREMOR (Shaking). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. In April 2022, MUSCLE SPASMS (Muscle spasm) and TREMOR (Shaking) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2020, SARS-CoV-2 test: Positive. In November 2020, SARS-CoV-2 test: Positive.         No concomitant medication was reported.   No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Patient did not felt cold, patient used a blanket. She would go through it for half hour on and off. The muscle spasm lasted for 3 hours. Patient was nervous about receiving another booster. Patient was not taking other medication. Patient had COVID-19 positive on 09-Mar-2020. Symptoms was began on 09-Mar-2020. patient felt woozy, Cough for 3 hours straight, Phlegm in the throat. Patient received treatment medication as Claritin and Tylenol. Hospitalization was not required. On 20/21 Nov-2020 Patient had COVID-19 positive test. Symptoms was began on 20-Nov-2020. No treatment medication was received. Hospitalization was not required.   This case was linked to MOD-2022-662409 (Patient Link).
Bell's Palsy; Numbness in her gums in her mouth; Missed 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of BELL'S PALSY (Bell's Palsy) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced BELL'S PALSY (Bell's Palsy) (seriousness criterion medically significant), HYPOAESTHESIA ORAL (Numbness in her gums in her mouth) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed 2nd dose). At the time of the report, BELL'S PALSY (Bell's Palsy) and HYPOAESTHESIA ORAL (Numbness in her gums in her mouth) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed 2nd dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was on several unknown medications daily. Treatment includes 60mg Prednisone for 7 days and many unknown medication for treatment   Company Comment  Based on the current available information and temporal association between the use of the product and the start date of the events( Bell's palsy and hypoaesthesia oral) , a causal relationship cannot be excluded. This report also refers to a case of inappropriate schedule of product administration for mRNA-1273
anaphylaxis; This is a literature report for the following literature source(s).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANAPHYLACTIC REACTION (medically significant), outcome "unknown", described as "anaphylaxis". In another study, anaphylaxis was confirmed after the first dose in 7 patients who received BNT-162b2 vaccine and 9 patients who received mRNA-1273 vaccine. The CDC had reported a rate of 2.5 cases per million doses.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the event cannot be completely excluded.,Linked Report(s) : US-PFIZER INC-202200705502 Same article/ drug/event and different patient:;US-PFIZER INC-202200706126 Same article/ drug/event and different patient:
I got the second dose around 2PM I had chills starting around 8PM I then was sweating and feverish for a couple hours, extremely achy, and also run down At 1AM I passed out after getting extremely nauseous...not sure if from dehydration or the sickness It took until 2 days later to feel normal again
Pfizer pediatric dose was administered to patient without diluent. The Pfizer pediatric vaccine vial was not prepared with the 1.3 mL of diluent as per the CDC guidelines.  No symptoms were reported by the family when waiting for observation.
Case number PHEH2014US024617 is an initial spontaneous report received from a health care professional on 05 Dec 2014. This report refers to a 73 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 145701, expiry date: Mar 2015) on an unknown date. It was reported that she started itching all over the body after the hour of administration of vaccine. Over the hours, itching got worse and she had to seek medical attention. At the time of evaluation, she had red streaks on the arms and breast. The events outcome, seriousness and causality were not reported.
Arm pain; Fever; Chills; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain), PYREXIA (Fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Arm discomfort, at an unspecified dose and frequency and NAPROXEN (MOTRIN [NAPROXEN]) for Arm discomfort, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain) outcome was unknown and PYREXIA (Fever) and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported.
Patient presented to the ED and was subsequently hospitalized for altered mental status, alcohol abuse,  within 6 weeks of receiving second covid vaccination.
itchy left arm, around the injection site; Big red rash around the injection site; swollen left arm, around the injection site; sore mild symptoms on left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore mild symptoms on left arm), VACCINATION SITE RASH (Big red rash around the injection site), VACCINATION SITE PRURITUS (itchy left arm, around the injection site) and VACCINATION SITE SWELLING (swollen left arm, around the injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore mild symptoms on left arm). On 13-Jan-2021, the patient experienced VACCINATION SITE RASH (Big red rash around the injection site), VACCINATION SITE PRURITUS (itchy left arm, around the injection site) and VACCINATION SITE SWELLING (swollen left arm, around the injection site). In January 2021, VACCINATION SITE PAIN (sore mild symptoms on left arm) had resolved. At the time of the report, VACCINATION SITE RASH (Big red rash around the injection site), VACCINATION SITE PRURITUS (itchy left arm, around the injection site) and VACCINATION SITE SWELLING (swollen left arm, around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment medication was not used by the patient. The sore mild symptoms on her left arm went away with the days ( don´t know the exact date).   This case was linked to MOD21-05339 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Numbness progressing from right deltoid (site of injection), down into right flank of abdomen, then up right side of neck, and facial numbness covering all of face. This lasted for three hours, then all numbness went away.
Moderna COVID-19 Vaccine EUA body aches, headache red rash, tough skin with itching
1st shot myocarditis 2nd  fever , chills hard to get out of bed
Had fever (100.9°F); Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Had fever (100.9°F)) and FATIGUE (Fatigue) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B and 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SINUPROL for Heart disorder, LISINOPRIL and OMEPRAZOLE for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced PYREXIA (Had fever (100.9°F)) and FATIGUE (Fatigue). At the time of the report, PYREXIA (Had fever (100.9°F)) and FATIGUE (Fatigue) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 100.9 degree f (High) 100.9 degree F.         No treatment information was provided.
1 of 9 pts immunized from same lot 366949; not the same vial; who exp induration & poss erythematous nodule approx 2 inches in diameter @ the inj site; nodule persisted 6-8 wks;
significant local reaction of erythema, seen 3days after vaccination , left thigh with 4.5in x 3in area of redness, sl warm, nontender, advised observation and rto if increase s/s